Norbert W. Bischofberger

2010

In 2010, Norbert W. Bischofberger earned a total compensation of $3.8M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 10% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$665,039
Option Awards$1,091,736
Salary$712,090
Stock Awards$1,302,000
Other$5,000
Total$3,775,865

Bischofberger received $1.3M in stock awards, accounting for 34% of the total pay in 2010.

Bischofberger also received $665K in non-equity incentive plan, $1.1M in option awards, $712.1K in salary and $5K in other compensation.

Rankings

In 2010, Norbert W. Bischofberger's compensation ranked 1,490th out of 10,439 executives tracked by ExecPay. In other words, Bischofberger earned more than 85.7% of executives.

ClassificationRankingPercentile
All
1,490
out of 10,439
86th
Division
Manufacturing
532
out of 3,837
86th
Major group
Chemicals And Allied Products
106
out of 925
89th
Industry group
Drugs
61
out of 684
91st
Industry
Biological Products, Except Diagnostic Substances
10
out of 147
93rd
Source: SEC filing on March 19, 2013.

Bischofberger's colleagues

We found five more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2010.

2010

John Martin

Gilead Sciences

Chief Executive Officer

2010

John Milligan

Gilead Sciences

Chief Operating Officer

2010

Kevin Young

Gilead Sciences

Executive Vice President, Commercial Operations

2010

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

2010

Robin Washington

Gilead Sciences

Chief Financial Officer

You may also like